| Original language | English |
|---|---|
| Pages (from-to) | 890-902 |
| Number of pages | 13 |
| Journal | American Journal of Health-System Pharmacy |
| Volume | 81 |
| Issue number | 18 |
| DOIs |
|
| State | Published - Sep 15 2024 |
Funding
This project was supported in part by the National Institutes of Health (NIH) under award K23DK128562 (principal investigator, Dr. Flannery) and K08DK124658 (principal investigator, Dr. Miano). The funding source had no role in study design; data collection, analysis, or interpretation; writing the report; or the decision to submit the report for publication. Dr. Flannery currently serves as an associate editor for AJHP. The other authors have declared no potential conflicts of interest.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | K08DK124658, K23DK128562 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- clinical trials
- critical care
- endpoints
- outcomes
- research
ASJC Scopus subject areas
- Pharmacy
- Pharmacology
- Health Policy
Fingerprint
Dive into the research topics of 'The times are changing: A primer on novel clinical trial designs and endpoints in critical care research'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver